基本信息
浏览量:2
职业迁徙
个人简介
Dr. Pamela Goodwin is a medical oncologist who provides clinical consultation to breast cancer patients
She has been involved with breast cancer research for over 20 years, focusing on the role of lifestyle and genetic factors in the development and clinical course of breast cancer. She has identified insulin as an important growth factor in women with breast cancer.
One of Dr Goodwin's studies showed that breast cancer patients' participation in support groups helped with psychological distress, but did not influence survival
In a 2008 study, Dr. Goodwin uncovered a link between vitamin D deficiency and poor prognosis of breast cancer
Dr. Goodwin has focused her research activities in the area of breast cancer. She has a longstanding interest in the role of obesity and nutrition-related factors in breast cancer development and recurrence. Dr. Goodwin has recently turned her attention to research into strategies to reduce the impact of obesity and other lifestyle factors on breast cancer outcomes, focusing on weight loss and the potential impact of metformin, an insulin lowering drug commonly used to treat diabetes, on breast cancer outcomes.
She has been involved with breast cancer research for over 20 years, focusing on the role of lifestyle and genetic factors in the development and clinical course of breast cancer. She has identified insulin as an important growth factor in women with breast cancer.
One of Dr Goodwin's studies showed that breast cancer patients' participation in support groups helped with psychological distress, but did not influence survival
In a 2008 study, Dr. Goodwin uncovered a link between vitamin D deficiency and poor prognosis of breast cancer
Dr. Goodwin has focused her research activities in the area of breast cancer. She has a longstanding interest in the role of obesity and nutrition-related factors in breast cancer development and recurrence. Dr. Goodwin has recently turned her attention to research into strategies to reduce the impact of obesity and other lifestyle factors on breast cancer outcomes, focusing on weight loss and the potential impact of metformin, an insulin lowering drug commonly used to treat diabetes, on breast cancer outcomes.
研究兴趣
论文共 236 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 12001-12001
引用0浏览0引用
0
0
Journal of Clinical Oncologyno. 8 (2023): 1499-1500
引用0浏览0WOS引用
0
0
Journal of Clinical Oncologyno. 35 (2023): 5356-+
Ana Elisa Lohmann,Marguerite Ennis,Pamela Jean Goodwin,Zachary William Neil Veitch, Christine Brezden,Katarzyna Joanna Jerzak, Kathie Baer, Samuel Martel,Julie Lemieux, Jose Luiz Miranda Guimaraes,David W. Cescon,Michael P. Thirlwell,
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 1028-1028
引用0浏览0引用
0
0
引用0浏览0WOS引用
0
0
JAMAno. 20 (2022)
CANCER RESEARCHno. 4 (2022)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn